US Stock MarketDetailed Quotes

HOOK HOOKIPA Pharma

Watchlist
  • 0.766
  • -0.002-0.22%
Close May 13 16:00 ET
  • 0.752
  • -0.014-1.87%
Post 19:58 ET
75.83MMarket Cap-1596P/E (TTM)

About HOOKIPA Pharma Company

HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.

Company Profile

SymbolHOOK
Company NameHOOKIPA Pharma
Listing DateApr 18, 2019
Issue Price14.00
Founded2011
CEOMr. Joern Aldag
MarketNASDAQ
Employees179
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address350 Fifth Avenue,72nd floor, Suite 7240
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone43-1-890-6360
Websitehttp://www.hookipapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Joern Aldag
  • Chief Executive Officer and Director
  • 1.13M
  • Mark Winderlich
  • Chief Development Officer
  • --
  • Klaus Orlinger
  • Chief Scientific Officer
  • --
  • Roman Necina
  • Chief Operations Officer
  • --
  • Reinhard Kandera
  • Chief Financial Officer, Director and Principal Accounting Officer
  • 725.48K
  • Dr. Jan G. J. van de Winkel, PhD
  • Chairman of the Board
  • 127.98K
  • Dr. Malte Peters, M.D.
  • Director
  • 232.31K
  • Dr. Timothy P. Reilly, PhD
  • Director
  • 71.74K
  • Terry Coelho
  • Director
  • 85.88K
  • David Ross Kaufman
  • Independent Director
  • 71.74K
  • Julie O'Neill
  • Independent Director
  • 67.74K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg